IonQ Demonstrates Quantum-Accelerated Workflow for Drug Discovery with AstraZeneca, AWS, and NVIDIA

IonQ has announced a multi-party collaboration with AstraZeneca, AWS, and NVIDIA to demonstrate a hybrid quantum-classical workflow aimed at accelerating early-stage pharmaceutical development. The workflow, showcased at ISC High Performance 2025, achieved a 20x speedup in time-to-solution compared to previous approaches while modeling catalytic steps in Suzuki-Miyaura cross-coupling—a reaction class essential to small-molecule drug synthesis. […]

The post IonQ Demonstrates Quantum-Accelerated Workflow for Drug Discovery with AstraZeneca, AWS, and NVIDIA appeared first on Quantum Computing Report.